Aptose Biosciences Inc. (APTO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.18M |
| Enterprise Value | 3.44M |
| P/E Ratio | -0.16 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | 0.52 |
| Return On Equity | -0.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 22,000 |
| Net Income | 0 |
| Diluted EPS | -10.41 |
| Total Cash | 1.02M |
| Total Cash/Share | 0.4 |
| Total Debt | 80,000 |
| Total Debt/Equity | -0 |
| Current Ratio | 0.55 |
| Book Value Per Share | -13.58 |
| 52-Week Change | -50.86 |
| 52-Week High | 43.19 |
| 52-Week Low | 1.1 |
| Moving Average 50 Days | 3.93 |
| Moving Average 200 Days | 9.25 |
| Average Volume | 223,276 |
| Shares Outstanding | 2.55M |
| % Held by Institutions | 0.98 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | February 26, 2025 |